Shanghai Pharmaceuticals Holding Co., Ltd
SHPMF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.41B
Close$
$4.36
198.9% upside
Current Fair Value
198.9% upsideUndervalued by 198.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $5.41 Billion |
|---|---|
| Enterprise Value | $37.73 Billion |
| Annual dividend | $0.07 |
| Dividend yield | 3.53% |
| Earnings per Share | $1.54 |
| Beta | 0.16 |
| Outstanding Shares | 3,708,361,809 |
Return
| Return on Equity | 6.08% |
|---|---|
| Return on Assets | 1.97% |
| Return on Invested Capital | 11.85% |
Valuation & Multiples
| P/E Ratio | 12.53 |
|---|---|
| PEG | -37.49 |
| Price to Sales | 0.02 |
| Price to Book Ratio | 0.06 |
| Enterprise Value to Revenue | 0.13 |
| Enterprise Value to EBIT | 3.15 |
| Enterprise Value to Net Income | 7 |
| Total Debt to Enterprise | 1.78 |
| Debt to Equity | 0.86 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$0.10
Consensus analyst estimateRevenue Estimate
$11.17 B
Consensus analyst estimateNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.04
Consensus analyst estimateRevenue Estimate
$11.28 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Shanghai Pharmaceuticals Holding Co., Ltd
49,608 employees
CEO: Qiuhua Yang
Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company based in Shanghai, People's Republic of China, maintains a robust presence across the pharmaceutical and healthcare industries. Its core activities involve the res...